A huge quarter for Ozempic and Wegovy maker Novo Nordisk is masking a longer-term challenge
Soaring demand for weight loss injectables boosted Danish drugmaker Novo Nordisk’s sales 29% year-over-year in the third quarter, with revenues of ...
Read more